Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

The first five years of a child's life are crucial when it comes to preventing obesity in the future, according to researchers.Experts in the Netherlands found body mass index (BMI) at age six is a ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Individuals who lived with obesity as children are less likely to be in work or studying in their mid-20s than their peers, ...

I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s lead author said.

Childhood overweight and obesity are a growing public health challenge in South Africa. In 2016, 13% of the country's ...

Researchers used data-driven clustering to define 6 distinct obesity subtypes, offering a potential paradigm shift in how ...

Weight-loss injections known as GLP-1 receptor agonists could nearly halve the risk of obesity-related cancers, according to ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...